BioCentury | Jul 16, 2012
Clinical News

Cx601: Phase III started

...perianal fistulas who failed previous treatment. TiGenix received a €5 million ($6.1 million) loan from Madrid Network...
BioCentury | Oct 31, 2011
Financial News

2B BlackBio completes venture financing

...Spain Business: Diagnostic Date completed: 10/25/11 Type: Venture financing Raised: €1.9 million ($2.6 million) Investors: Madrid Network...
BioCentury | Oct 10, 2011
Financial News

TiGenix completes debt financing

...Musculoskeletal, Gene/Cell therapy Date completed: 10/3/11 Type: Debt financing Raised: €2 million ($2.6 million) Investor: Madrid Network...
Items per page:
1 - 3 of 3
BioCentury | Jul 16, 2012
Clinical News

Cx601: Phase III started

...perianal fistulas who failed previous treatment. TiGenix received a €5 million ($6.1 million) loan from Madrid Network...
BioCentury | Oct 31, 2011
Financial News

2B BlackBio completes venture financing

...Spain Business: Diagnostic Date completed: 10/25/11 Type: Venture financing Raised: €1.9 million ($2.6 million) Investors: Madrid Network...
BioCentury | Oct 10, 2011
Financial News

TiGenix completes debt financing

...Musculoskeletal, Gene/Cell therapy Date completed: 10/3/11 Type: Debt financing Raised: €2 million ($2.6 million) Investor: Madrid Network...
Items per page:
1 - 3 of 3